Status:
COMPLETED
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Cervical Cancer
Ovarian Cancer
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
Some patients, specifically those with a diagnosed genetic mutation, will have their ovaries and fallopian tubes removed without removal of the uterus in an attempt to prevent ovarian and fallopian tu...
Eligibility Criteria
Inclusion
- Women undergoing a non-emergent total hysterectomy with removal of the tubes and ovaries by the gynecologic service for benign or malignant conditions uterine, cervical or early ovarian cancer.
- Patients will undergo either a laparotomy, total laparoscopy or laparoscopically assisted vaginal hysterectomy
- Patients will be 21 years and older.
Exclusion
- Patients with abnormal fallopian tubes seen preoperatively by radiologic exam or intraoperatively by visual inspection.
- Patients who are suspected to have fallopian tube cancer prior to their surgery
- Patients who have had prior pelvic radiation therapy
- Patients who are undergoing a Robotically Assisted procedure
- Patients who have had any type of prior tubal surgery
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00746018
Start Date
August 1 2008
End Date
July 1 2017
Last Update
April 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering
New York, New York, United States, 10065